BCLI - Brainstorm Cell Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BCLI is currently covered by 1 analysts with an average price target of $5.78. This is a potential upside of $5.35 (1244.19%) from yesterday's end of day stock price of $0.43.

Brainstorm Cell Therapeutics's activity chart (see below) currently has 5 price targets and 9 ratings on display. The stock rating distribution of BCLI is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 706.5 days.

Highest price target for BCLI is $3, Lowest price target is $3, average price target is $5.78.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 28-Sep-2023. First documented stock forecast 20-Jan-2015.

Best performing analysts who are covering BCLI - Brainstorm Cell Therapeutics:

Jason Kolbert Jason Mccarthy

Currently out of the existing stock ratings of BCLI, 1 are a BUY (50%), 1 are a HOLD (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

5

8 months 20 days ago

1/3 (33.33%)

$1.7 (51.52%)

132

Buy

12

$11.65 (3328.57%)

5 years 5 months 30 days ago

2/2 (100%)

$8.99 (298.67%)

1281

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BCLI (Brainstorm Cell Therapeutics) average time for price targets to be met?

On average it took 706.5 days on average for the stock forecasts to be realized with a an average price target met ratio 66.67

Which analyst has the current highest performing score on BCLI (Brainstorm Cell Therapeutics) with a proven track record?

JASON KOLBERT

Which analyst has the current lower performing score on BCLI (Brainstorm Cell Therapeutics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on BCLI (Brainstorm Cell Therapeutics)?

Jason Kolbert works at DAWSON JAMES and has 2 price targets and 6 ratings on BCLI

Which analyst is the currently most bullish on BCLI (Brainstorm Cell Therapeutics)?

Jason Kolbert with highest potential upside - $11.65

Which analyst is the currently most reserved on BCLI (Brainstorm Cell Therapeutics)?

Jason Mccarthy with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?